SCHEMBL7056781

SCHEMBL7056781

CCCC[N]C(CC)CC

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.33
LMNA P02545 2/20 0.33
THRB P10828 1/20 0.32
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9205938 0.83 LMNA (0.38) TSHRLMNATHRBCA2
SCHEMBL9213518 0.83 LMNA (0.38) TSHRLMNATHRBCA2
SCHEMBL7609905 0.81
SCHEMBL9208910 0.78 LMNA (0.38) TSHRLMNATHRBCA2
SCHEMBL9204339 0.78 LMNA (0.38) TSHRLMNATHRBCA2
SCHEMBL9206246 0.78 LMNA (0.38) TSHRLMNATHRBCA2
SCHEMBL9212471 0.78 DNM1 (0.42) TSHRLMNATHRBCA2
SCHEMBL270258 0.74
SCHEMBL269743 0.73
SCHEMBL1998265 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994108-B1 PROCESS FOR PRODUCING 2-HYDROXYBENZAMIDE DERIVATIVES ZERIA PHARM CO LTD (JP) 2003-05-14 EP disclosed
US-6197970-B1 REACTING WITH SECONDARY OR TERTIARY AMINE; DEBLOCKING, DEPROTECTING ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0994108-A1 PROCESS FOR PRODUCING 2-HYDROXYBENZAMIDE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 2000-04-19 EP disclosed